Large-scale testing (Phase 3)Looking for participantsNCT04777357
What this trial is testing
Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
Who this might be right for
DepressionBipolar I Disorder
AbbVie 380